Expression of beta-catenin in hepatocellular carcinoma - PubMed (original) (raw)
Expression of beta-catenin in hepatocellular carcinoma
Liem Thanh Tien et al. World J Gastroenterol. 2005.
Abstract
Aim: The beta-catenin has been recognized as a critical member of the Wnt signaling pathway and plays an important role in the generation/differentiation of many tissues. Inappropriate activation of this pathway has been implicated in carcinogenesis. The mechanism underlying the development as well as its prognosis of hepatocellular carcinoma (HCC) has remained unclear. The purpose of this study is to analyze the expression of beta-catenin in HCC in relation to histological grades and viral hepatitis backgrounds.
Methods: Thirty-two sections were selected at random from autopsy and surgical cases of HCC. Immunohistologically, the location and positivity of beta-catenin expression in HCC was examined.
Results: Normal hepatocytes did not express beta-catenin. In 78% of HCC beta-catenin was expressed at the membrane of the cells, with or without cytoplasmic and/or nuclear expression. The tumor cells with well- and moderately-differentiated grades expressed frequently at the membrane and cytoplasm compared with poorly-differentiated type. Nuclear expression of beta-catenin was prone to occur in the tumor cells of poorly-differentiated grade. There were 15% of hepatitis C virus (HCV) backgrounds with nuclear expression. In contrast, there was 38% with nuclear expression in hepatitis B virus (HBV) backgrounds. In nonB-nonC hepatitis, no case expressed nuclear beta-catenin.
Conclusion: The beta-catenin expression in HCC cells was heterogeneous among types of hepatitis viral infection. Wnt signaling pathway might be deeply involved in less-differentiated HCC and HBV background.
Figures
Figure 1
Constitutive expression of β-catenin in normal bile ducts. Membranous expression is conspicuous in normal bile ducts and newly formed bile ducts (arrow heads), but no expression is observed in normal hepatocytes.
Figure 2
Membranous expression. Membranous expression is conspicuous in tumor cell membranes. This case is moderately-differentiated HCC.
Figure 3
Nuclear expression. Nuclear expression is encountered in the poorly-differentiated HCC (arrows). Most cells co-expressed β-catenin in the cytoplasm.
Figure 4
Localization of β-catenin expression in cell level. M: membranous, M+C: membranous and cytoplasmic, M+N: membranous and nuclear, M+N+C: membranous, cytoplasmic, and nuclear, C: cytoplasmic.
Similar articles
- [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
Bae SH, Jung ES, Park YM, Jang JW, Choi JY, Cho SH, Yoon SK, Ahn BM, Cha SB, Chung KW, Sun HS, Park DH, Kim BK, Kim DG. Bae SH, et al. Taehan Kan Hakhoe Chi. 2002 Sep;8(3):297-303. Taehan Kan Hakhoe Chi. 2002. PMID: 12499787 Korean. - beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.
Wong CM, Fan ST, Ng IO. Wong CM, et al. Cancer. 2001 Jul 1;92(1):136-45. doi: 10.1002/1097-0142(20010701)92:1<136::aid-cncr1301>3.0.co;2-r. Cancer. 2001. PMID: 11443619 - Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL, Peng SY. Hsu HC, et al. Am J Pathol. 2000 Sep;157(3):763-70. doi: 10.1016/s0002-9440(10)64590-7. Am J Pathol. 2000. PMID: 10980116 Free PMC article. - Alterations of Wnt/β-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis C virus.
Rogacki K, Kasprzak A, Stępiński A. Rogacki K, et al. Pol J Pathol. 2015 Mar;66(1):9-21. doi: 10.5114/pjp.2015.51148. Pol J Pathol. 2015. PMID: 26017875 Review. - Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
Kim Y, Sills RC, Houle CD. Kim Y, et al. Toxicol Pathol. 2005;33(1):175-80. doi: 10.1080/01926230590522130. Toxicol Pathol. 2005. PMID: 15805069 Review.
Cited by
- Identification and analysis of key genes related to efferocytosis in colorectal cancer.
Zhang S, Jiang Y, Shi L, Wei T, Lai Z, Feng X, Li S, Tang D. Zhang S, et al. BMC Med Genomics. 2024 Aug 6;17(1):198. doi: 10.1186/s12920-024-01967-8. BMC Med Genomics. 2024. PMID: 39107816 Free PMC article. - The Loss of an Orphan Nuclear Receptor NR2E3 Augments Wnt/β-catenin Signaling via Epigenetic Dysregulation that Enhances Sp1-β catenin-p300 Interactions in Hepatocellular Carcinoma.
Leung YK, Lee SG, Wang J, Guruvaiah P, Rusch NJ, Ho SM, Park C, Kim K. Leung YK, et al. Adv Sci (Weinh). 2024 Aug;11(29):e2308539. doi: 10.1002/advs.202308539. Epub 2024 May 24. Adv Sci (Weinh). 2024. PMID: 38790135 Free PMC article. - Association between the expression of epithelial-mesenchymal transition (EMT)-related markers and oncologic outcomes of colorectal cancer.
Emile MH, Emile SH, El-Karef AA, Ebrahim MA, Mohammed IE, Ibrahim DA. Emile MH, et al. Updates Surg. 2024 May 18. doi: 10.1007/s13304-024-01865-9. Online ahead of print. Updates Surg. 2024. PMID: 38762631 - ctDNA as a novel and promising approach for cancer diagnosis: a focus on hepatocellular carcinoma.
Biglari N, Soltani-Zangbar MS, Mohammadian J, Mehdizadeh A, Abbasi K. Biglari N, et al. EXCLI J. 2023 Aug 3;22:752-780. doi: 10.17179/excli2023-6277. eCollection 2023. EXCLI J. 2023. PMID: 37720239 Free PMC article. Review. - Combining Crocin and Sorafenib Improves Their Tumor-Inhibiting Effects in a Rat Model of Diethylnitrosamine-Induced Cirrhotic-Hepatocellular Carcinoma.
Awad B, Hamza AA, Al-Maktoum A, Al-Salam S, Amin A. Awad B, et al. Cancers (Basel). 2023 Aug 11;15(16):4063. doi: 10.3390/cancers15164063. Cancers (Basel). 2023. PMID: 37627094 Free PMC article.
References
- Calvisi DF, Factor VM, Ladu S, Conner EA, Thorgeirsson SS. Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice. Gastroenterology. 2004;126:1374–1386. - PubMed
- Ozturk M. Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis. 1999;19:235–242. - PubMed
- Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, Eilers R, Dienes HP, Schirmacher P. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. J Pathol. 2003;201:250–259. - PubMed
- Torbenson M, Kannangai R, Abraham S, Sahin F, Choti M, Wang J. Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma. Am J Clin Pathol. 2004;122:377–382. - PubMed
- Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology. 2002;36:692–701. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous